Go Pro

62,575 Shares in CME Group Inc. $CME Bought by Haverford Trust Co

CME Group logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Haverford Trust Co. bought 62,575 CME Group shares worth approximately $13.8 million in the second quarter. Institutional investors collectively own 87.75% of the company.
  • CME Group exceeded quarterly expectations, reporting $2.99 in EPS and $1.71 billion in revenue, while revenue rose 0.8% year over year.
  • The company declared a quarterly dividend of $1.30 per share, or $5.20 annually, yielding about 1.9%. Analysts maintain a consensus “Hold” rating with an average price target of $288.56.
  • Interested in CME Group? Here are five stocks we like better.

Haverford Trust Co purchased a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 62,575 shares of the financial services provider's stock, valued at approximately $13,818,000.

Other large investors also recently modified their holdings of the company. Bridgewater Advisors Inc. purchased a new stake in shares of CME Group in the second quarter worth about $612,000. FLC Capital Advisors purchased a new stake in shares of CME Group during the 4th quarter valued at about $2,122,000. HighTower Advisors LLC lifted its position in CME Group by 6.9% during the 4th quarter. HighTower Advisors LLC now owns 352,922 shares of the financial services provider's stock worth $96,376,000 after acquiring an additional 22,692 shares in the last quarter. TD Private Client Wealth LLC lifted its position in CME Group by 132.7% during the 4th quarter. TD Private Client Wealth LLC now owns 21,228 shares of the financial services provider's stock worth $5,797,000 after acquiring an additional 12,105 shares in the last quarter. Finally, North Dakota State Investment Board purchased a new position in CME Group in the 4th quarter worth approximately $3,368,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Price Performance

Shares of CME opened at $274.98 on Friday. The firm has a market cap of $98.88 billion, a price-to-earnings ratio of 23.32, a PEG ratio of 3.20 and a beta of 0.23. The stock has a 50 day moving average of $251.17 and a 200-day moving average of $279.65. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 52 week low of $218.31 and a 52 week high of $329.16.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating analysts' consensus estimates of $2.91 by $0.08. The business had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The business's quarterly revenue was up .8% on a year-over-year basis. During the same period in the previous year, the business earned $2.96 EPS. As a group, analysts forecast that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be paid a dividend of $1.30 per share. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 annualized dividend and a yield of 1.9%. CME Group's payout ratio is presently 44.11%.

Insiders Place Their Bets

In other CME Group news, Director William R. Shepard bought 325 shares of the company's stock in a transaction on Thursday, June 25th. The shares were bought at an average cost of $230.57 per share, with a total value of $74,935.25. Following the completion of the acquisition, the director owned 260,442 shares of the company's stock, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.30% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

CME has been the subject of several recent research reports. Wall Street Zen downgraded shares of CME Group from a "sell" rating to a "strong sell" rating in a research report on Saturday, August 1st. The Goldman Sachs Group lowered their price target on shares of CME Group from $267.00 to $245.00 and set a "sell" rating for the company in a report on Tuesday, June 30th. Barclays dropped their price target on shares of CME Group from $316.00 to $270.00 and set an "equal weight" rating on the stock in a research note on Thursday, July 9th. Rothschild & Co Redburn upgraded shares of CME Group from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $316.00 to $323.00 in a report on Thursday, June 11th. Finally, Bank of America upped their price objective on shares of CME Group from $226.00 to $230.00 and gave the company an "underperform" rating in a research report on Thursday, July 23rd. Nine equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $288.56.

Get Our Latest Stock Analysis on CME

CME Group Company Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Featured Articles

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines